Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term dna-repair. Found 13 abstracts

Husain H, Psyrri A, Markovic A, Rampias T, Pectasides E, Wang H, Slebos R, Yarbrough WG, Burtness B, Chung CH. Nuclear epidermal growth factor receptor and p16 expression in head and neck squamous cell carcinoma. The Laryngoscope. 2012 Dec;122(12):2762-8.   PMCID: PMC3574977
Park DJ, Lesueur F, Nguyen-Dumont T, Pertesi M, Odefrey F, Hammet F, Neuhausen SL, John EM, Andrulis IL, Terry MB, Daly M, Buys S, Le Calvez-Kelm F, Lonie A, Pope BJ, Tsimiklis H, Voegele C, Hilbers FM, Hoogerbrugge N, Barroso A, Osorio A, Giles GG, Devilee P, Benitez J, Hopper JL, Tavtigian SV, Goldgar DE, Southey MC. Rare Mutations in XRCC2 Increase the Risk of Breast Cancer. American journal of human genetics. 2012 Apr;90(4):734-9.   PMCID: PMC3322233
Gong Y, Huo L, Liu P, Sneige N, Sun X, Ueno NT, Lucci A, Buchholz TA, Valero V, Cristofanilli M. Polycomb group protein EZH2 is frequently expressed in inflammatory breast cancer and is predictive of worse clinical outcome. Cancer. 2011 Dec;117(24):5476-84.   PMCID: not NIH funded
Dominguez-Brauer C, Brauer PM, Chen YJ, Pimkina J, Raychaudhuri P. Tumor suppression by ARF Gatekeeper and caretaker. Cell cycle (Georgetown, Tex). 2010 Jan;9(1):86-9.   PMCID: *
Ozols R. Treatment of gynecologic cancer: The US experience. Tumori. 1999 May;85(3):S5-S11.
Chan DW, Gately DP, Urban S, Galloway AM, Lees-Miller SP, Yen T, Allalunis-Turner J. Lack of correlation between ATM protein expression and tumour cell radiosensitivity. International Journal of Radiation Biology. 1998 Aug;74(2):217-24.
Feng JA, Crasto CJ, Matsumoto Y. Deoxyribose phosphate excision by the N-terminal domain of the polymerase beta: The mechanism revisited. Biochemistry. 1998 Jul 07;37(27):9605-11.
Wan XS, Hamilton TC, Ware JH, Donahue JJ, Kennedy AR. Growth inhibition and cytotoxicity induced by Bowman-Birk inhibitor concentrate in cisplatin-resistant human ovarian cancer cells. Nutrition and Cancer-an International Journal. 1998 Jan;31(1):8-17.
Lidor YJ, Obriant KC, Xu FJ, Hamilton TC, Ozols RF, Bast RC. Alkylating-Agents and Immunotoxins Exert Synergistic Cytotoxic Activity against Ovarian-Cancer Cells - Mechanism of Action. Journal of Clinical Investigation. 1993 Nov;92(5):2440-7.
Perez RP, Hamilton TC, Ozols RF, Young RC. Mechanisms and Modulation of Resistance to Chemotherapy in Ovarian-Cancer. Cancer. 1993 Feb 15;71(4):1571-80.
Ozols RF. Role of Chemotherapy in the Future Treatment of Ovarian-Cancer. Acta Obstetricia Et Gynecologica Scandinavica. 1992 Jan;71:55-60.
Ozols RF. Role of Carboplatin in Ovarian-Cancer - Current Results and Thoughts for the Future. Acta Obstetricia Et Gynecologica Scandinavica. 1992 Jan;71:75-7.
Perez RP, Handel LM, Hamilton TC. Potentiation of Cisplatin Cytotoxicity in Human Ovarian- Carcinoma Cell-Lines by Trifluoperazine, a Calmodulin Inhibitor. Gynecologic Oncology. 1992 Jul;46(1):82-7.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term dna-repair

dna-repair cisplatin cyto-toxicity cell-lines carcinoma glutathione buthionine sulfoximine resistant lines resistance cancer chemotherapy alkylating-agents survival damage proliferation ataxia-telangiectasia gene cancer-cells genetic instability germline mutations purification escherichia-coli muty nucleotide excision-repair epithelial-cells catalytic subunit mediated glutathione depletion activation inflammatory breast cancer monoclonal-antibodies biology translocation immunoconjugates mechanisms encodes embryonic stem-cells in-vivo bone-marrow support cells binding in-vitro zeste homolog-2 transport nuclear EGFR Head and neck squamous cell carcinoma-p16 receptor susceptibility gene gene-expression p53 brca2 family registry enzyme endonuclease-iii drug synergy cis-diamminedichloroplatinum(ii) egfr mammalian-cells breast-cancer carcinoma cell-lines survival parameters drug- strand break repair prognosis marker human ovarian-cancer c-myc expression enhancer of zeste homolog 2 expression enhancer ifosfamide kinase tumor-cells disease human epidermal growth factor receptor 2 protein kinase activity ovarian-cancer histone methyltransferase ezh2 gynecologic oncology group carboplatin down-regulation product lung- multidrug recombination cisplatin cyto- antagonists human-papillomavirus lesions protease inhibitor carcinoma cells radioresponsiveness rad51c oropharyngeal cancer toxicity v(d)j melanoma estrogen interstrand cross-linking radiation dose intensity prostate-cancer site ovarian neoplasms drug-resistant tumor suppressor ARF-E2F4-XPC-DNA repair
Last updated on Friday, January 03, 2020